Form 4: Vor Biopharma CEO Robert Ang Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
CEO Robert Ang disposed of 2,361 shares of Vor Biopharma Inc. to cover tax obligations related to the settlement of restricted stock units.
Summary
- On November 6, 2024, Robert Ang, the President and CEO of Vor Biopharma Inc., disposed of 2,361 shares of common stock.
- The transaction was executed to satisfy tax withholding obligations related to the settlement of restricted stock units.
- The shares were sold at a price of $0.86 per share.
- Following the transaction, Ang beneficially owns 787,487 shares of Vor Biopharma Inc.
Sentiment
Score: 5
Explanation: The document reflects a routine transaction (selling shares to cover taxes) and doesn't inherently indicate positive or negative sentiment about the company's prospects.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track management's sentiment and actions regarding their company's stock.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it is a standard procedure for covering tax obligations.
Key Dates
| Date | Description |
|---|---|
| 11/06/2024 | Date of transaction where shares were disposed of to cover tax obligations. |
| 11/08/2024 | Date of signature by Attorney-in-Fact. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.